Briacell Therapeutics Corp · TSX:BCT
Citadel Advisors LLC reported a 9.99% stake in Briacell Therapeutics Corp (Schedule 13G)
Event Jan 15, 2026 · Filed Jan 23, 2026
Citadel Advisors LLC reported a 9.99% stake in Briacell Therapeutics Corp, 717,198 shares, as a passive investor on Jan 15, 2026. Filed Jan 23, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 717,198
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 9.98% | 716,699 |
| Citadel Advisors Holdings LP | 9.98% | 716,699 |
| Citadel GP LLC | 9.98% | 716,699 |
| Citadel Securities LLC | 0% | 499 |
| Citadel Securities Group LP | 0% | 499 |
| Citadel Securities GP LLC | 0% | 499 |
| Kenneth Griffin | 9.99% | 717,198 |